Tactile Systems Technology, Inc.
Health
Performance
6.7
Risk
Sell
Buy
Curious about the Scores? Learn more.

Tactile Systems Technology, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

20.07.2026
Back on its feet. Fundamentals looking less chaotic.
20.07.2026
Short-term strength kicking in. Early signs of life.
09.07.2026
Trouble brewing. Volatility and pressure rising.
19.04.2026
Health’s picking up. Numbers look cleaner, cash flow tighter.
TCMD
Tactile Systems Technology, Inc.
28.43
+0.14%
6.7
Sell
Buy
Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Tactile Systems Technology, Inc. do? Business model and key facts

Get the full picture of Tactile Systems Technology, Inc.: what it builds, where it operates, and how it makes money.

Tactile Systems Technology, Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 1086

Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.

shop
Company facts
Sheri Louise Dodd
CEO
1086
Employees worldwide
shop
Performance
194.31%
Last 12 months
-40.54%
Last 5 years
shop
Growth
$329.52M
Revenue year
$19.09M
Net income
shop
Valuation
$648.27M
Market Cap
34.94
Price/Earnings Ratio

Stocks related to Tactile Systems Technology, Inc.

Selected based on industry alignment and relative market positioning.

SIBN
SI-BONE, Inc.
17.04
-0.47%
5.7
Sell
Buy
SI-BONE, Inc.
BVS
Bioventus Inc.
11.88
+2.59%
5.3
Sell
Buy
Bioventus Inc.
INMD
InMode Ltd.
15.36
+0.00%
3.6
Sell
Buy
InMode Ltd.
CERS
Cerus Corporation
3.12
-0.95%
8.2
Sell
Buy
Cerus Corporation
SRDX
Surmodics, Inc.
42.98
+0.35%
4.2
Sell
Buy
Surmodics, Inc.

Events and news impacting Tactile Systems Technology, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Tactile Systems Technology, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.